Open Payments

The Stamford Hospital

Type
Teaching hospital
Where
Stamford, CT
Medicare CCN
070006
Received
$608,360 in 85 records, 2021 ($8,897 general, $599,462 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2021General payment23$8,897
2021Research payment62$599,462

By company

CompanyRecordsAmountYears
Genentech, Inc.6$376,3612021
F. Hoffmann-La Roche AG7$95,8712021
Incyte Corporation4$24,8592021
AKEBIA THERAPEUTICS INC18$24,0952021
AstraZeneca Pharmaceuticals LP3$18,8942021
Celgene Corporation2$17,8032021
EMD Serono, Inc.7$16,0642021
Janssen Research & Development, LLC2$8,9322021
Bayer Healthcare Pharmaceuticals Inc.1$7,6302021
CSL Behring6$6,9632021
Tandem Diabetes Care, Inc.13$6,2502021
ABBVIE INC.3$1,2252021
Boston Scientific Corporation3$9872021
Johnson & Johnson Health Care Systems Inc.2$5372021
Ethicon US, LLC1$5002021
Medtronic, Inc.2$5002021
Olympus America Inc.1$3212021
Amgen Inc.1$2752021
Siemens Medical Solutions USA, Inc.1$2262021
Helena Laboratories Corporation1$362021
Bio-Rad Laboratories, Inc.1$252021

By nature of payment

NatureRecordsAmount
Research payment62$599,462
Compensation for services other than consulting, including serving as faculty or as a speaker at a v15$6,750
Space rental or facility fees (teaching hospital only)2$1,000
Debt forgiveness4$789
Gift1$321
Food and Beverage1$36

Records

DateCompanyAmountNatureFormProductStudyYear
2021-12-31AstraZeneca Pharmaceuticals LP$3,635Research paymentIn-kind items and servicesFASENRA Biological, RespiratoryA Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate th2021
2021-12-31Siemens Medical Solutions USA, Inc.$226Debt forgivenessIn-kind items and services2021
2021-12-29Tandem Diabetes Care, Inc.$600Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-12-22Johnson & Johnson Health Care Systems Inc.$432Debt forgivenessIn-kind items and services2021
2021-12-22Johnson & Johnson Health Care Systems Inc.$105Debt forgivenessIn-kind items and services2021
2021-12-15EMD Serono, Inc.$550Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-12-15EMD Serono, Inc.$225Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-12-13Medtronic, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMinimed 770G System Device, Durable Pump2021
2021-12-09AKEBIA THERAPEUTICS INC$7,200Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-12-09AKEBIA THERAPEUTICS INC$810Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-12-08Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-11-30Bayer Healthcare Pharmaceuticals Inc.$7,630Research paymentCash or cash equivalentNon-CoveredBAY1002670 Long term Safety vs SoC2021
2021-11-19Genentech, Inc.$20,035Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2021
2021-11-18Genentech, Inc.$6,461Research paymentCash or cash equivalent DrugSINGLE AGENT GDC 9545 VS ENDOCRINE MONOTHERAPY ADJUVANT TREATMENT IN HR EBC2021
2021-11-11Genentech, Inc.$2,850Research paymentCash or cash equivalent DrugSINGLE AGENT GDC 9545 VS ENDOCRINE MONOTHERAPY ADJUVANT TREATMENT IN HR EBC2021
2021-11-10Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-11-05Ethicon US, LLC$500Space rental or facility fees (teaching hospital only)Cash or cash equivalentVISTASEAL Biological, Biosurgical2021
2021-11-03Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-10-29Bio-Rad Laboratories, Inc.$25Debt forgivenessCash or cash equivalentBiotestcell 1 & 2 Device, Antiglobulin test2021
2021-10-27Tandem Diabetes Care, Inc.$600Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-10-26CSL Behring$500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2021
2021-10-12AKEBIA THERAPEUTICS INC$225Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-10-12AKEBIA THERAPEUTICS INC$216Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-10-11Genentech, Inc.$220Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2021
2021-10-05F. Hoffmann-La Roche AG$54,791Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-10-05F. Hoffmann-La Roche AG$13,673Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-10-05F. Hoffmann-La Roche AG$6,758Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-10-05Janssen Research & Development, LLC$4,527Research paymentCash or cash equivalentA Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locall2021
2021-10-05F. Hoffmann-La Roche AG$3,500Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-10-05F. Hoffmann-La Roche AG$770Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-10-01AstraZeneca Pharmaceuticals LP$10,261Research paymentCash or cash equivalentFASENRA Biological, RespiratoryA Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate th2021
2021-09-29Incyte Corporation$9,311Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxo2021
2021-09-29Incyte Corporation$9,311Research paymentCash or cash equivalentA Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kd Inhibitor Parsaclisib Plus Ruxolitinib in Participants2021
2021-09-22Tandem Diabetes Care, Inc.$400Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-09-21Medtronic, Inc.$200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentMinimed 770G System Device, Durable Pump2021
2021-09-20EMD Serono, Inc.$3,053Research paymentCash or cash equivalentBavencio Drug, OncologyPATRIOT II US Prospective 1st Line Maintenance of Avelumab in UC-20202021
2021-09-14Helena Laboratories Corporation$36Food and BeverageIn-kind items and services2021
2021-09-10Janssen Research & Development, LLC$4,405Research paymentCash or cash equivalentA Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locall2021
2021-09-09F. Hoffmann-La Roche AG$5,060Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-09-08Tandem Diabetes Care, Inc.$1,900Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-09-07Boston Scientific Corporation$270Research paymentCash or cash equivalentVARIOUS RELEASED ICD FAMILIES Device, Clinical Trial ProductINVESTIGATIONAL STUDY TO INFORM GUIDANCE IN PROGRAMMING HEAR2021
2021-09-02AKEBIA THERAPEUTICS INC$675Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-09-02AKEBIA THERAPEUTICS INC$648Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-08-18Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-08-05ABBVIE INC.$500Research paymentCash or cash equivalentORILISSA Drug, WOMENS HEALTHA Multicenter, Observational Cohort Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Att2021
2021-08-05ABBVIE INC.$500Research paymentCash or cash equivalentORILISSA Drug, WOMENS HEALTHA Multicenter, Observational Cohort Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Att2021
2021-08-05ABBVIE INC.$225Research paymentCash or cash equivalentORILISSA Drug, WOMENS HEALTHA Multicenter, Observational Cohort Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Att2021
2021-07-22AKEBIA THERAPEUTICS INC$542Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-07-15AKEBIA THERAPEUTICS INC$2,168Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-07-15AKEBIA THERAPEUTICS INC$1,620Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-07-15AKEBIA THERAPEUTICS INC$575Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-07-13AKEBIA THERAPEUTICS INC$675Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-07-13AKEBIA THERAPEUTICS INC$648Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-07-09Genentech, Inc.$338,250Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyPHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC2021
2021-07-08AKEBIA THERAPEUTICS INC$882Research paymentCash or cash equivalentAKB-6548-CI-00142021
2021-06-24AKEBIA THERAPEUTICS INC$1,005Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-06-24AKEBIA THERAPEUTICS INC$750Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-06-22AKEBIA THERAPEUTICS INC$450Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-06-22AKEBIA THERAPEUTICS INC$432Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-06-16CSL Behring$2,530Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2021
2021-06-16CSL Behring$2,000Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2021
2021-06-16CSL Behring$1,000Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2021
2021-06-16CSL Behring$225Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2021
2021-06-04EMD Serono, Inc.$6,461Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-06-04EMD Serono, Inc.$2,850Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-06-04EMD Serono, Inc.$2,725Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-06-04EMD Serono, Inc.$200Research paymentCash or cash equivalentA Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresect2021
2021-05-17Boston Scientific Corporation$224Research paymentCash or cash equivalentVARIOUS RELEASED ICD FAMILIES Device, Clinical Trial ProductINVESTIGATIONAL STUDY TO INFORM GUIDANCE IN PROGRAMMING HEAR2021
2021-04-21Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-04-06F. Hoffmann-La Roche AG$11,317Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncologyALL COMERS SSF2021
2021-03-18AstraZeneca Pharmaceuticals LP$4,998Research paymentCash or cash equivalentIMFINZI Biological, OncologyA Non-Interventional Primary Data Collection Study to Assess the Prevalence of PD-L1 High in First Line Metastatic and L2021
2021-03-17Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-03-15Boston Scientific Corporation$493Research paymentCash or cash equivalentVARIOUS RELEASED ICD FAMILIES Device, Clinical Trial ProductINVESTIGATIONAL STUDY TO INFORM GUIDANCE IN PROGRAMMING HEAR2021
2021-03-11Celgene Corporation$5,803Research paymentCash or cash equivalentPomalyst Drug, HematologyA phase 2, multicenter, multi-cohort, open-label s2021
2021-03-09AKEBIA THERAPEUTICS INC$4,574Research paymentCash or cash equivalentAKB-6548-CI-00152021
2021-02-23CSL Behring$708Research paymentIn-kind items and servicesA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2021
2021-02-10Tandem Diabetes Care, Inc.$550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-02-03Tandem Diabetes Care, Inc.$250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-02-02Celgene Corporation$12,000Research paymentCash or cash equivalentConnect MM- The Multiple Myeloma Disease Registry2021
2021-01-22Genentech, Inc.$8,545Research paymentCash or cash equivalentTECENTRIQ Biological, BioOncology1L MTNBC IPATASERTIB TECENTRIQ PACLITAXEL2021
2021-01-22Amgen Inc.$275Research paymentIn-kind items and servicesNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC.2021
2021-01-20Incyte Corporation$5,072Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2021
2021-01-20Incyte Corporation$1,165Research paymentCash or cash equivalentPROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED 2021
2021-01-06Tandem Diabetes Care, Inc.$300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentt-slim insulin pump Device, Endocrinology2021
2021-01-01Olympus America Inc.$321GiftIn-kind items and servicesOlympus Device, Energy2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Western Connecticut Planning RegionStamford city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Stamford, CT, county Western Connecticut Planning Region, CT, state Connecticut; placed by its city name.

MeasurePlace (city or town)
Stamford, CT
County
Western Connecticut Planning Region, CT
State
Connecticut
Population B01003137,144627,0713,624,508
Population, 2020 census P1135,470-3,605,944
Median age B0100238.441.541.1
Under 18 B0100118.4%21.8%20.2%
65 and over B0100116.2%17.4%18.5%
Households B1100155,291235,3791,434,007
Foreign born B0500231.3%23.8%15.7%
Median household income B19013$111,586$128,188$95,781
Median family income B19113$126,493$161,625$122,706
Per capita income B19301$67,068$82,266$55,915
Poverty rate B1700110.1%7.5%10.0%
Unemployment rate B230254.9%5.3%5.6%
Civilian labor force B2302581,944346,5571,959,490
Mean commute (minutes) B0801328.530.826.5
Bachelor's degree or higher B1500351.7%55.5%42.5%
Housing units B2500158,655251,5301,541,822
Owner-occupied B2500348.8%66.4%66.5%
Renters B2500351.2%33.6%33.5%
Median home value B25077$624,400$652,900$366,900
Median gross rent B25064$2,276$2,110$1,488
White, not Hispanic B0300243.2%58.6%61.9%
Black B0300217.7%9.3%9.8%
Hispanic or Latino B0300228.3%20.5%18.3%
Asian B030027.3%5.4%4.7%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 5.1% in Sep 2026 (4.2% a year earlier); per capita personal income $102,307 in 2025, up 33% in five years (+7.1% after inflation); Unemployment rate: 4.7% in Sep 2016 to 5.1% in Sep 2026; low 3.1%, high 11.9% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Stamford, CT.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.